Cargando…

Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”

Detalles Bibliográficos
Autor principal: Acconcia, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499552/
https://www.ncbi.nlm.nih.gov/pubmed/36142174
http://dx.doi.org/10.3390/ijms231810265
_version_ 1784795019339628544
author Acconcia, Filippo
author_facet Acconcia, Filippo
author_sort Acconcia, Filippo
collection PubMed
description
format Online
Article
Text
id pubmed-9499552
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94995522022-09-23 Editorial for the Special Issue “New Drugs for Breast Cancer Treatment” Acconcia, Filippo Int J Mol Sci Editorial MDPI 2022-09-06 /pmc/articles/PMC9499552/ /pubmed/36142174 http://dx.doi.org/10.3390/ijms231810265 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Acconcia, Filippo
Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”
title Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”
title_full Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”
title_fullStr Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”
title_full_unstemmed Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”
title_short Editorial for the Special Issue “New Drugs for Breast Cancer Treatment”
title_sort editorial for the special issue “new drugs for breast cancer treatment”
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499552/
https://www.ncbi.nlm.nih.gov/pubmed/36142174
http://dx.doi.org/10.3390/ijms231810265
work_keys_str_mv AT acconciafilippo editorialforthespecialissuenewdrugsforbreastcancertreatment